IP Strategy Announces Share Repurchase Plan to 1M Shares
IP Strategy said its board approved a buyback of up to 1,000,000 common shares through Dec. 31, 2026, potentially tri...
Zero Based Budgeting Journey Stories
Discover real-world outcomes from Zero Based Budgeting Journey Stories as single parents share their budgeting wins, challenges, and practical tips.
16,981 articles
Stocks Double Right: Top Picks to Buy Now for 2026
Finding winning stocks isn’t about chasing the hottest trend. It’s about identifying durable catalysts, solid fundame...
Gold SLVP Silver: Which ETF Should You Buy Now for 2026
Are you trying to decide between gold miners and silver miners? This guide breaks down GDX vs SLVP, highlighting cost...
FedEx Sues Trump Admin for Tariff Refunds After IEEPA Ruling
FedEx filed a lawsuit seeking full refunds of IEEPA-era tariffs after a Supreme Court ruling restricted presidential ...
Bitcoin Traders Expect More Pain Ahead as BTC Drops
After a dramatic fall, Bitcoin traders expect more pain ahead as BTC slips from its peak. This guide breaks down what...
Stock That Insiders Loading: AI Stock to Watch in 2026
Insider buying can reveal confidence that outsiders may miss. This guide breaks down how to read the signals, separat...
Why Netflix Stock Climbed Today: Key Drivers Behind Rally
Netflix stock climbed today as investors weighed growth momentum and the potential move of a major deal. This article...
Vistance (VISN) 2025 Earnings: What Investors Must Know Now
Vistance (VISN) reports for 2025 show meaningful progress in revenue and margins, but the real story is how the compa...
Salesforce Stock After Strong Earnings: Buy or Hold After the Beat
Salesforce just delivered a solid quarter with revenue and adjusted earnings topping expectations and a $50 billion b...
Altman Tells Staff All-Hands OpenAI Eyes Pentagon Deal
OpenAI is in talks with the U.S. Department of Defense on a potential AI services contract, with safeguards and deplo...
When Turn Really Want: Why I Might Skip Medicare Advantage
As retirement nears, the choice between Original Medicare and Medicare Advantage becomes personal. This piece shares ...
Is Crispr Therapeutics Stock Risky Right Now? A Practical Guide for Investors
Biotech stocks can swing on clinical data and regulatory news. This guide digs into whether crispr therapeutics stock...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status